Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Neostigmine for Post-Dural Puncture Headache in C-Section
NCT03587441Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of neostigmine in post-dural puncture headache (PDPH) (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Incidence of post-dural puncture headache at Day 5. Started Aug 2018; status: completed.
02
Drugs
neostigmine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03587441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587441.